George Mina, DPM
Podiatrist · Phillipsburg, NJNPI 1396130316
Payments from drug & device makers
Across 58 payments — averaging $41.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vilex LLC$962
- Access Pro Medical, LLC$188
- Boston Scientific$170
- Convatec Inc.$141
- Alfasigma USA, Inc.$119
- KCI USA, Inc.$94
- plus $728 from 19 others
What the payments were for
- Travel & lodging$94939%
- Food & beverage$1,41459%
- Education$402%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vilex LLC | 6 | $962 |
| Access Pro Medical, LLC | 2 | $188 |
| Boston Scientific | 1 | $170 |
| Convatec Inc. | 1 | $141 |
| Alfasigma USA, Inc. | 9 | $119 |
| KCI USA, Inc. | 3 | $94 |
| Integra Lifesciences Corporation | 3 | $88 |
| Paratek Pharmaceuticals, Inc. | 3 | $67 |
| Treace Medical Concepts, Inc. | 2 | $64 |
| Reflow Medical Inc | 1 | $56 |
| Abiomed | 3 | $54 |
| Bioventus LLC | 3 | $54 |
| Smith+Nephew | 4 | $51 |
| Organogenesis Inc. | 3 | $47 |
| Paragon 28, Inc. | 3 | $39 |
| Novus Surgical Consultants | 1 | $37 |
| SPR Therapeutics, Inc | 1 | $31 |
| IBSA Pharma Inc. | 2 | $24 |
| Abbott | 1 | $23 |
| Innovation Technologies Inc | 1 | $18 |
| Mimedx Group, Inc. | 1 | $17 |
| Kerecis Limited | 1 | $15 |
| Zimmer Biomet | 1 | $14 |
| Amgen | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALPHALOK$813
- Peripheral RotaLink Plus$170
- Matriderm$159
- InnovaMatrix AC$141
How this compares
$2,403 in reported general payments places this provider in the 70th percentile of 382 podiatrist providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 45 | $41,429 |
| Ciclopirox | 91 | $3,549 |
| Ammonium Lactate | 110 | $2,682 |
| Gabapentin | 186 | $1,144 |
| Mupirocin | 151 | $1,134 |
| Doxycycline Hyclate | 106 | $974 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 34 | $834 |
| Diclofenac Sodium | 29 | $797 |
| Meloxicam | 219 | $655 |
| Linezolid | 12 | $608 |
| Fluocinonide | 16 | $378 |
| Terbinafine Hcl | 27 | $358 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 23 | $176 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $137 |
| Methylprednisolone | 16 | $114 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Phillipsburg
- Justin FlemingSomerset$1.2M
- Eric BaskinManahawkin$298K
- Jonathan RichardsEnglewood$79K
- Jack BondiSewell$53K
- Matthew WohlgemuthHammonton$49K
- Ritchard RosenEnglewood$44K
- Michael HuchitalLyndhurst$41K
- Jeffrey GewirtzPark Ridge$24K
- James SullivanSea Girt$19K
- Georgios KotziasParamus$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.